Enables 14-3-3 protein binding activity and aralkylamine N-acetyltransferase activity. Involved in several processes, including response to copper ion; response to corticosterone; and response to prostaglandin E. Predicted to be located in perinuclear region of cytoplasm. Predicted to be active in cytoplasm. Used to study type 2 diabetes mellitus. Human ortholog(s) of this gene implicated in advanced sleep phase syndrome. Orthologous to human AANAT (aralkylamine N-acetyltransferase); PARTICIPATES IN tryptophan metabolic pathway; INTERACTS WITH (R)-noradrenaline; ammonium chloride; bisphenol A.
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid inhibits the reaction [Norepinephrine results in increased activity of AANAT protein]; Cannabidiol inhibits more ...
Regulation of cAMP-induced arylalkylamine N-acetyltransferase, Period1, and MKP-1 gene expression by mitogen-activated protein kinases in the rat pineal gland.
Rhythmic expression of adenylyl cyclase VI contributes to the differential regulation of serotonin N-acetyltransferase by bradykinin in rat pineal glands.
Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors.
Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status.
Accumulation of rat pineal serotonin N-acetyltransferase mRNA induced by pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide in vitro.
Prostaglandin E2 increases adenosine 3',5'-monophosphate concentration and binding-site occupancy, and stimulates serotonin-N-acetyltransferase activity in rat pineal glands in vitro.
Melatonin synthesis: analysis of the more than 150-fold nocturnal increase in serotonin N-acetyltransferase messenger ribonucleic acid in the rat pineal gland.